K-1012

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameK-1012
Drug Alias Namebi-phosphate derivative of cannabidiol (Kalytera Therapeutics)cannabidiol prodrug (Kalytera Therapeutics)K-1012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid modulators
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKalytera Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalytera Therapeutics
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A